# US 2023/0390105 A1 · Methods and devices for controlled delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0390105 A1
- Document ID: US20230390105A1
- Status: Published application
- Kind: A1
- Application number: 18/236,109
- Filed: 2023-08-21
- Published: 2023-12-07
- Earliest claimed: 2018-05-02
- Assignees: Femasys Inc.
- Applicants: Femasys Inc.
- Inventors: Kathy Lee-Sepsick
- Web page: https://patentgrep.com/patent/US20230390105A1

## CPC

- A61F 6/22: implantable in tubes {(occluding by internal devices A61B17/12022)}
- A61B 17/1204: {temporary occlusion}
- A61F 6/18: Inserters or removers
- A61F 6/20: Vas deferens occluders; Fallopian occluders
- A61L 24/001: {Use of materials characterised by their function or physical properties}
- A61L 24/0015: {Medicaments; Biocides}
- A61L 24/0031: {Hydrogels or hydrocolloids}
- A61L 24/0042: {Materials resorbable by the body}
- A61L 24/046: {obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence)}
- A61L 24/06: obtained by reactions only involving carbon-to-carbon unsaturated bonds {(A61L24/043, A61L24/046 take precedence)}
- A61M 25/0074: {Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable}
- A61M 25/0136: {Handles therefor}
- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61L 2400/06: Flowable or injectable implant compositions
- A61M 2210/1425: Uterine tubes
- A61M 2210/1433: Uterus
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Disclosed herein are exemplary medical devices for controlled delivery of material compositions, particularly occlusive, therapeutic, or diagnostic compositions.

## Claims

### Claim 1

A method for occluding at least one fallopian tube in a human or animal body, comprising,
a) providing a controlled delivery device capable of delivering an effective amount of a composition comprising an occlusive material, wherein the delivery device comprises at least an insertion tube for providing at least one catheter; at least one catheter, comprising an end structure on a delivery end that maintains the delivery end in at least one uterine cornua and aids in localized delivery of the one or more compositions; a handle; a system plunger controlled by a lock that is reversible coupled to a control rod, and a material cartridge containing the composition comprising an occlusive material positioned within a receptacle in the handle;
b) delivering an effective amount of the composition comprising an occlusive material at or near the target site such that the material occludes the lumen of the fallopian; and
c) occluding the conduit with the composition comprising an occlusive material within the lumen of the conduit.

### Claim 2 (depends on 1)

The method of claim 1, wherein two fallopian tubes are occluded without removal and re-introduction or substantial repositioning of the controlled delivery device.

### Claim 3 (depends on 1)

The method of claim 1, wherein the composition comprising an occlusive material comprises a biodegradable cyanoacrylate composition.

### Claim 4 (depends on 3)

The method of claim 3, wherein the composition, when cured, swells less than 20%.

### Claim 5 (depends on 3)

The method of claim 3, wherein the composition is about 20% to about 100% substantially resorbed in a range of about 30 to about 365 days.

### Claim 6 (depends on 1)

The method of claim 1, wherein the occlusion is maintained by tissue ingrowth.

### Claim 7 (depends on 1)

The method of claim 1, wherein the composition further comprises tissue scarring agents, fibrosis agents, fertilization inhibitors, contraceptive agents, tissue growth promoters, hormones, polymerization inhibitors, polymerization stabilizers, emulsifying agents, echogenic agents, contrast agents, viscosity-modifying materials, plasticizers, colorants or combinations thereof.

### Claim 8 (depends on 1)

The method of claim 1, wherein the composition further comprises a curable carrier for the occlusive materials, a control release agent, tissue scarring agents, fibrosis agents, fertilization inhibitors, contraceptive agents, tissue growth promoters, hormones, polymerization inhibitors, polymerization stabilizers, emulsifying agents, echogenic agents, contrast agents, viscosity-modifying materials, plasticizers, colorants or combinations thereof.

### Claim 9

A method for contraception, comprising,
a) providing a delivery system capable of delivering an effective amount of a composition comprising an occlusive material, wherein the delivery device comprises at least an insertion tube for providing at least one catheter; at least one catheter, comprising an end structure on a delivery end that maintains the delivery end in at least one uterine cornua and aids in localized delivery of the one or more compositions; a handle; a system plunger controlled by a lock that is reversible coupled to a control rod, and a material cartridge containing the composition comprising an occlusive material positioned within a receptacle in the handle;
b) delivering an effective amount of the composition comprising an occlusive material at or near the target location such that the material occludes the lumen of at least one fallopian tube; and
c) occluding the fallopian tube with the composition comprising an occlusive material within the lumen of the conduit.

### Claim 10

A contraceptive device, comprising at least an insertion tube for providing at least one catheter; at least one catheter, comprising an end structure on a delivery end that maintains the delivery end in at least one uterine cornua and aids in localized delivery of the one or more compositions; a handle; a system plunger controlled by a lock that is reversible coupled to a control rod, and a material cartridge containing the composition comprising an occlusive material positioned within a receptacle in the handle.

### Claim 11 (depends on 10)

The device of claim 10, wherein the end structure is a cup, nozzle, or a balloon.

### Claim 12

A method of diagnosis and treatment, comprising,
(a) providing one or more compositions to at least a portion of at least one fallopian tube of a human or animal by a delivery system that delivers an effective amount of the one or more compositions, and wherein the delivery device comprises at least an insertion tube for providing at least one catheter; at least one catheter, comprising an end structure on a delivery end that maintains the delivery end in at least one uterine cornua and aids in localized delivery of the one or more compositions; a handle; a system plunger controlled by a lock that is reversible coupled to a control rod, and a material cartridge containing the composition comprising an occlusive material positioned within a receptacle in the handler;
(b) delivering an effective amount of the first composition such that the first composition enters at least a portion of the at least one fallopian tube.

### Claim 13

An occlusive composition, comprising,
a) a cyanoacrylate component comprising at least one cyanoacrylate, wherein the cyanoacrylate component is 80 wt % or greater;
b) a stabilizer component in a range from 500 ppm to 1500 ppm; and
c) a polymerization inhibitor component in a range from 4000 to 7000 ppm.

### Claim 14 (depends on 13)

The occlusive composition position of claim 13, wherein the cyanoacrylate component comprises at least two cyanoacrylate monomers.

### Claim 15 (depends on 13)

The occlusive composition of claim 13, wherein the cyanoacrylate monomer is methyl cyanoacrylate, ethyl cyanoacrylate, propyl cyanoacrylate, butyl cyanoacrylate, pentyl cyanoacrylate, hexyl cyanoacrylate, septyl cyanoacrylate, octyl nonyl cyanoacrylate, decyl 2-cyanoacrylate, allyl cyanoacrylate, methoxy ethyl cyanoacrylate, methoxy isopropyl cyanoacrylate, methoxypropyl cyanoacrylate, methoxybutyl cyanoacrylate, methoxypentyl cyanoacrylate, or combinations thereof.

### Claim 16 (depends on 13)

The occlusive composition of claim 13, wherein the stabilizer component comprises an alkyl sulfide, alkyl sulfate, alkyl sulfonyl, alkyl sulfone, alkyl sulfoxide, alkyl sulfite, sultone, sulfur dioxide, sulfur trioxide, sulfonic acid, lactone, boron trifluoride, acetic acid, or 3-sulfolene, mercaptan, or combinations thereof.

### Claim 17 (depends on 16)

The occlusive composition of claim 16, wherein the stabilizer component comprises sulfur dioxide or sulfur trioxide.

### Claim 18 (depends on 1)

The occlusive composition of claim 1, wherein the polymerization inhibitor component comprises butylated hydroxy anisole (BHA); hydroquinone; catechol; hydroquinone monomethyl ether and hindered phenols such as butylated hydroxyanisol; 4-ethoxy phenol; butylated hydroxytoluene (BHT, 2,6-di-tert-butyl butylphenol), 4-methoxy phenol (MP); 3-methoxy phenol; 2-tert-butyl-4-methoxyphenol; or 2,2-methylene-bis-(4-methyl-6-tert-butylphenol), or combinations thereof.

### Claim 19 (depends on 6)

The biodegradable cyanoacrylate composition of claim 6, wherein the polymerization inhibitor component comprises BHA or BHT.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7)

The biodegradable cyanoacrylate composition of any one of claims 1-7, further comprising hydrogen sulfide, carbonic acid, triacetylmethane, acetic acid, benzoic acid, dinitrophenol, formic acid, nitrous acid, hydrochloric acid, hydrobromic acid, hydrofluoric acid, chloroacetic acid, phosphoric acid, dichloroacetic acid, trichloroacetic acid, trinitrophenol, trifluoroacetic acid, sulfuric acid, perchloric acid, toluenesulfonic acid, or fluorosulfonic acid, or combinations thereof.
